Medicare Enrolled
Dr. John Chawluk, M.D.
Neurology · Pottsville, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chawluk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chawluk?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chawluk
Dr. John Chawluk is a neurology specialist in Pottsville, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Chawluk performed 1,338 Medicare services across 1,067 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chawluk received a total of $273,851 from 65 pharmaceutical and/or device companies across 774 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chawluk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 10% volume in PA
$273,851 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,338
Medicare services
Top 10% in PA for neurology
1,067
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~64 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
378 | $84 | $190 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
181 | $118 | $266 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
174 | $57 | $134 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
118 | $71 | $194 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
73 | $25 | $61 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
73 | $25 | $61 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
72 | $96 | $220 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
66 | $115 | $410 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $43 | $82 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
36 | $46 | $178 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
31 | $55 | $115 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
23 | $147 | $410 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
22 | $22 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $115 | $257 |
| New patient office visit, complex (60-74 min) | 18 | $143 | $319 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$273,851
Total received (2018-2024)
Avg $39,122/year across 7 years
Top 4% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
774
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$261,724 (95.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,127 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,306
2023
$30,087
2022
$65,727
2021
$89,430
2020
$43,864
2019
$26,293
2018
$9,144
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$8,138
Eisai Inc.
$153
UCB, Inc.
$88
SK Life Science, Inc.
$84
ACADIA Pharmaceuticals Inc
$81
EMD Serono, Inc.
$60
Otsuka America Pharmaceutical, Inc.
$57
PFIZER INC.
$56
Amneal Pharmaceuticals LLC
$55
CSL Behring
$54
Genentech USA, Inc.
$43
Biogen, Inc.
$43
Neurocrine Biosciences, Inc.
$40
Celgene Corporation
$35
Teva Pharmaceuticals USA, Inc.
$32
Kyowa Kirin, Inc.
$24
Medtronic, Inc.
$23
Lilly USA, LLC
$23
Axsome Therapeutics, Inc.
$22
TG Therapeutics, Inc.
$21
Xeris Pharmaceuticals, Inc.
$21
CATALYST PHARMACEUTICALS, INC.
$20
MDD US Operations, LLC
$18
Alexion Pharmaceuticals, Inc.
$18
Sandoz Inc.
$18
Novartis Pharmaceuticals Corporation
$17
LivaNova USA, Inc.
$17
Lundbeck LLC
$16
ARGENX US, INC.
$16
Neurelis, Inc.
$14
Top 3 companies account for 90.0% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$71,444
Biohaven Pharmaceuticals, Inc.
$61,034
Biohaven Pharmaceutical Holding Company Ltd.
$44,597
ABBVIE INC.
$25,368
Allergan, Inc.
$21,346
AbbVie Inc.
$20,910
EMD Serono, Inc.
$17,458
Abbott Laboratories
$3,102
LivaNova USA, Inc.
$2,107
Eisai Inc.
$600
Alexion Pharmaceuticals, Inc.
$390
Novartis Pharmaceuticals Corporation
$343
SK Life Science, Inc.
$286
GENZYME CORPORATION
$273
Amneal Pharmaceuticals LLC
$260
Sunovion Pharmaceuticals Inc.
$254
Biogen, Inc.
$240
ACADIA Pharmaceuticals Inc
$226
Supernus Pharmaceuticals, Inc.
$219
Medtronic, Inc.
$203
Amgen Inc.
$176
US WorldMeds, LLC
$174
UCB, Inc.
$160
CSL Behring
$157
Celgene Corporation
$151
Neurocrine Biosciences, Inc.
$142
Lundbeck LLC
$140
E.R. Squibb & Sons, L.L.C.
$132
PFIZER INC.
$130
EISAI INC.
$128
Genentech USA, Inc.
$119
Acorda Therapeutics, Inc
$94
Avanir Pharmaceuticals, Inc.
$88
Janssen Pharmaceuticals, Inc
$87
Allergan Inc.
$84
Lilly USA, LLC
$83
Takeda Pharmaceuticals U.S.A., Inc.
$83
Adamas Pharmaceuticals, Inc.
$83
Axsome Therapeutics, Inc.
$83
Neurelis, Inc.
$81
Otsuka America Pharmaceutical, Inc.
$73
Greenwich Biosciences, Inc.
$70
CATALYST PHARMACEUTICALS, INC.
$67
Kyowa Kirin, Inc.
$67
ARGENX US, INC.
$52
Harmony Biosciences LLC
$49
TG THERAPEUTICS, INC.
$43
Impax Laboratories, Inc.
$41
JAZZ PHARMACEUTICALS INC.
$38
MDD US Operations, LLC
$32
ASSERTIO THERAPEUTICS, Inc.
$31
Bayer HealthCare Pharmaceuticals Inc.
$28
Medtronic USA, Inc.
$27
IMPEL PHARMACEUTICALS INC.
$23
TG Therapeutics, Inc.
$21
Xeris Pharmaceuticals, Inc.
$21
Life Molecular Imaging Ltd
$19
Sandoz Inc.
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$17
Jazz Pharmaceuticals Inc.
$16
ANI Pharmaceuticals, Inc.
$16
Assertio Therapeutics, Inc.
$14
Mallinckrodt Hospital Products Inc.
$13
Mallinckrodt Enterprises LLC
$11
Upsher-Smith Laboratories LLC
$11
Top 3 companies account for 64.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Apokyn · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · COPAXONE · Cambia · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · Fintepla · Fycompa · GI Genius · GILENYA · GOCOVRI · Gralise · Hizentra · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · LEMTRADA · LUMIZYME · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCREVUS · OXTELLAR XR · Ongentys · PANZYGA · PERCEPT PC BRAINSENSE · PLEGRIDY · PROCLAIM · PURIFIED CORTROPHIN GEL · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SENSIGHT · SOLIRIS · Soliris · Sunosi · TECFIDERA · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · WAKIX · Wakix · XCOPRI · XYREM · Xadago · Xyrem · ZARXIO · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in PA.
Geographic Context
Neurologists within 10 mi
6
Per 100K population
4.2
County median income
$66,901
Nearest hospital
SCHUYLKILL MEDICAL CENTER - SOUTH JACKSON STREET
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chawluk is a clinical cardiology specialist, with above-average Medicare volume (top 10% in PA), with speaking/promotional industry engagement in the top 4% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chawluk experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chawluk performed 378 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chawluk receive payments from pharmaceutical companies?
Yes. Dr. Chawluk received a total of $273,851 from 65 companies across 774 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chawluk's costs compare to other neurologists in Pottsville?
Dr. Chawluk's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chawluk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Pottsville
Browse neurologists in Pottsville ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in PA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in PA
Which PA neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology